Metagenics OmegaGenics EPA-DHA 1000
Background
Omega-3 supplements have gained an enormous level of popularity in the last few decades and they are currently one of the top 3 most widely used supplements in North America. The three main omega-3 fatty acids are ALA, EPA, and DHA with the latter two usually combined in one supplement. The following product will be geared towards EPA and DHA and if you are looking for an ALA containing product, please visit the following page. It is important to note that extensive research has shown Omega-3 fatty acids to provide a number of health benefits, some of which will be discussed in further detail.
Daily Omega-3 supplementation has been associated with improved cardiovascular health by lowering triglyceride levels and decreasing risks of future heart attacks. Additionally, other research has highlighted cognitive benefits of Omega-3 supplements where these fatty acids resulted in improvements of memory, attention, and executive function. Lastly, number of research has shown anti inflammatory properties of Omega-3 supplements to be effective in reducing joint pain and disease activity in patients with rheumatoid arthritis.
What OmegaGenics offers
OmegaGenics Omega-3 contains 1400mg of fish oil with 290mg of DHA and 710mg of EPA from fish oil. Unlike many other fish oil supplements, OmegaGenics does not have a fishy after taste and will not give customers fishy burps.
Why OmegaGenics
With their numerous health benefits ranging from anti-inflammatory properties to improved brain development and function, it is no surprise that more than half of Americans use Omega-3 fatty acid supplements daily. Although many supplement brands market their Omega-3s as safe and effective, often times third party testing of the said products show concerning levels of heavy metals and other contaminants. To give customers ease of mind and ensure their well-being and safety, Metagenics has partnered with a third party testing company. By entering the lot number into the website, customers can see the results of the batch testing done at the independent facility to further be assured their product is free of contaminants.
The high quality of ingredients and the emphasis on the safety aspect of their product is what makes OmegaGenics by Metagenics a go to omega-3 supplement.
Score being calculated and collected by Suptamins for OmegaGenics
Category | Sub Category | Score |
---|---|---|
Suptamin's Static Score | Form of the molecule found in product: | 1 |
Suptamin's Static Score | Presence of ingredient enhancing absorption | 1 |
Suptamin's Static Score | Unwanted ingredients and additives su | 1 |
Suptamin's Static Score | Clinical studies supporting the use of the product | 2 |
Suptamin's Static Score | Appropriate dosage and safety of taking the medication | 2 |
Suptamin's Static Score | Quality of ingredients and whether they are third party tested | 2 |
Suptamin's Static Score | Total score, out of 10 | 9 |
Suptamins Past Consumers Score | 3rd party, Amazon score, out of 10 | 0 |
Suptamins Past Consumers Score | Suptamins customers score | 0 |
Suptamins Past Consumers Score | Total score, out of 10 | 0 |
Suptamins Real Time Score | Effectiveness | 0 |
Suptamins Real Time Score | Quality | 0 |
Suptamins Real Time Score | Aggregate Customer rating | 0 |
Suptamins Real Time Score | Price | 0 |
Suptamins Real Time Score | Empirical data | 0 |
Suptamins Real Time Score | Total score, out of 10 | 0 |
Dosage and precautions for OmegaGenics
Directions: Take one softgel up to three times daily with food or as directed by your healthcare practitioner.
Caution: Consult your healthcare practitioner if pregnant, nursing, or taking other nutritional supplements or medications. Keep out of the reach of children.
This product is manufactured in a facility that processes soy and fish.
Click image to enlarge
Ingredients for OmegaGenics
Ingredient | Amount Per Serving | % Daily Value |
---|---|---|
Serving Size: 1 softgel | ||
Other Omega-3 Fatty Acid Triglycerides | 100 mg | ** |
DHA (Docosahexaenoic acid triglyceride) | 290 mg | ** |
EPA (Eicosapentaenoic acid triglyceride) | 710 mg | ** |
^Marine Lipid Concentrate | 1.4 g | ** |
Cholesterol | 5 mg | 2% |
Total Fat | 1.5 g | 2%* |
Calories | 15 |
^Marine Lipid concentrates fish (anchovy, sardine, and mackerel) oil
Softgel shell contains gelatin, glycerin, and water
Other Ingredients: 2% or less of natural lemon flavor, mixed tocopherols (antioxidant), rosemary extract, and ascorbyl palmitate (antioxidant)
Serving Size: 1 softgel
This product is non-GMO and gluten-free.
Servings Per Container: 60. Other serving size might also be available.
*Percent Daily Values are based on a 2,000 calorie diet.
**Daily Value not established.
References about OmegaGenics
Third parties review for Metagenics OmegaGenics
- Mozaffarian, D. (2016). Dietary and Policy Priorities for Cardiovascular Disease, Diabetes, and Obesity: A Comprehensive Review. Circulation, 133(2), 187-225.
Dyall, S. C. (2015). Long-chain omega-3 fatty acids and the brain: a review of the independent and shared effects of EPA, DPA, and DHA. Frontiers in Aging Neuroscience, 7, 52.
Goldberg, R. J., & Katz, J. (2007). A meta-analysis of the analgesic effects of omega-3 polyunsaturated fatty acid supplementation for inflammatory joint pain. Pain, 129(1-2), 210-223.
Alexander, D. D. et al. (2017). Meta-analysis of randomized controlled trials and prospective cohort studies of eicosapentaenoic and docosahexaenoic long-chain omega-3 fatty acids and coronary heart disease risk. Mayo Clinic Proceedings, 92(1), 15-29.
Dyall, S. C. (2015). Long-chain omega-3 fatty acids and the brain: a review of the independent and shared effects of EPA, DPA, and DHA. Frontiers in Aging Neuroscience, 7, 52.
Grosso, G. et al. (2014). Role of omega-3 fatty acids in the treatment of depressive disorders: a comprehensive meta-analysis of randomized clinical trials. PLoS One, 9(5), e96905.
Calder, P. C. et al. (2017). Omega-3 fatty acids and inflammatory processes: from molecules to man. Biochemical Society Transactions, 45(5), 1105-1115.
Serhan, C. N. et al. (2015). Resolution of inflammation: state of the art, definitions and terms. FASEB Journal, 29(1), 4-19.